Information Journal Paper
APA:
Copy. (2018). Diammonium Glycyrrhizinate Protects against Non-Alcoholic Fatty Liver Disease in mice through modulation of gut microbiota and restoring intestinal barrier. MOLECULAR PHARMACEUTICS, 15(9), 3860-3870. SID. https://sid.ir/paper/756455/en
Vancouver:
Copy. Diammonium Glycyrrhizinate Protects against Non-Alcoholic Fatty Liver Disease in mice through modulation of gut microbiota and restoring intestinal barrier. MOLECULAR PHARMACEUTICS[Internet]. 2018;15(9):3860-3870. Available from: https://sid.ir/paper/756455/en
IEEE:
Copy, “Diammonium Glycyrrhizinate Protects against Non-Alcoholic Fatty Liver Disease in mice through modulation of gut microbiota and restoring intestinal barrier,” MOLECULAR PHARMACEUTICS, vol. 15, no. 9, pp. 3860–3870, 2018, [Online]. Available: https://sid.ir/paper/756455/en